NCT01903356View on ClinicalTrials.gov

A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in Korea

CompletedOBSERVATIONAL
Enrollment

724

Participants

Timeline

Start Date

July 11, 2013

Primary Completion Date

May 30, 2017

Study Completion Date

June 10, 2017

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Trajenta duo

Linagliptin and Metformin

Trial Locations (1)

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY